Stoke Therapeutics annual revenue
2022
2023
2024
2025
Stoke Therapeutics Revenue Growth & History (STOK)
Stoke Therapeutics reported $184.4M in revenue for fiscal 2025, an increase of 404.50% from the previous fiscal year.
View full Stoke Therapeutics company overviewStoke Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $184.4M | $147.9M | +404.50% |
| 2024 | 2024-12-31 | $36.6M | $27.8M | +316.34% |
| 2023 | 2023-12-31 | $8.8M | −$3.6M | −29.22% |
| 2022 | 2022-12-31 | $12.4M | — | — |
Stoke Therapeutics quarterly revenue
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.3M | −$4.5M | −32.51% |
| Q1 2026 | 2026-03-31 | $6.2M | −$152.3M | −96.07% |
| Q4 2025 | 2025-12-31 | $1.4M | −$21.2M | −93.80% |
| Q3 2025 | 2025-09-30 | $10.6M | $5.7M | +117.25% |
| Q2 2025 | 2025-06-30 | $13.8M | $9.0M | +186.01% |
| Q1 2025 | 2025-03-31 | $158.6M | $154.4M | +3661.12% |
| Q4 2024 | 2024-12-31 | $22.6M | $19.8M | +707.35% |
| Q3 2024 | 2024-09-30 | $4.9M | $1.6M | +47.94% |
| Q2 2024 | 2024-06-30 | $4.8M | $7.3M | +294.72% |
| Q1 2024 | 2024-03-31 | $4.2M | −$936,000 | −18.17% |
| Q4 2023 | 2023-12-31 | $2.8M | −$468,000 | −14.32% |
| Q3 2023 | 2023-09-30 | $3.3M | $403,000 | +13.87% |
| Q2 2023 | 2023-06-30 | −$2.5M | −$5.7M | −176.79% |
| Q1 2023 | 2023-03-31 | $5.2M | $2.2M | +71.73% |
| Q4 2022 | 2022-12-31 | $3.3M | — | — |
| Q3 2022 | 2022-09-30 | $2.9M | — | — |
| Q2 2022 | 2022-06-30 | $3.2M | — | — |
| Q1 2022 | 2022-03-31 | $3.0M | — | — |
Stoke Therapeutics revenue growth trends
Stoke Therapeutics's latest reported quarter, Q2 2026, generated $9.3M in revenue, a decrease of 32.51% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Stoke Therapeutics source filings ↗